ClinicalTrials.gg
CompletedNCT03448107Updated Feb 26, 2025Results posted

Comparative Effectiveness of Treatments to Prevent Dental Caries

An interventional study of Silver Diamine Fluoride and Fluoride Varnishes in Dental Caries, sponsored by NYU College of Dentistry. Completed at 1 site in United States. Open to participants aged 5 Years to 12 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-02-26.

Sponsored by NYU College of Dentistry · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Sep 2017, registered Feb 2018).
Phase
Not applicable
Study type
Interventional
Enrollment
3,345
Allocation
Randomized
Ages
5 Years to 12 Years
Sex
All
01

Study summary

Dental caries (tooth decay) is the most prevalent childhood disease in the world. Multiple interventions are available to treat and prevent caries. The aim of the proposed study is to compare the benefit of silver diamine fluoride (SDF) and fluoride varnish versus fluoride varnish and glass ionomer sealants. This study is a five-year, cluster randomized, pragmatic controlled trial conducted in public elementary schools in New Hampshire.

Read the detailed description

Dental caries is the most prevalent childhood disease in the world and can lead to infection, pain, reduced quality of life, and negative educational outcomes. Multiple prevention agents are available to arrest and prevent dental caries, however little is known of the comparative effectiveness of combined treatments in pragmatic settings. The aim of the presented study is to compare the benefit of silver diamine fluoride and fluoride varnish versus fluoride varnish and glass ionomer therapeutic sealants in the arrest and prevention of dental caries.

This is a longitudinal, pragmatic, cluster randomized, single-blind, non-inferiority trial to be conducted in low-income children enrolled in public elementary schools in New Hampshire from 2017-2023. The primary objective is to assess the non-inferiority of alternative agents in the arrest and prevention of dental caries. Caries arrest will be evaluated after two years, and caries prevention will be assessed at the completion of the study. Data analysis will follow intent to treat, and statistical analyses will be conducted using a two-sided significance level of 0.05.

Notably, the standard of care for dental caries is office-based surgery, which presents multiple barriers to care including cost, fear, and geographic isolation. The simplicity and affordability of silver diamine fluoride may be a viable alternative for the arrest and prevention of dental caries in high-risk children.

02

Conditions studied

  • Dental Caries

Browse trials for

Keywords

  • dental caries
  • caries arrest
  • caries prevention
  • silver diamine fluoride
  • sealants
  • interim therapeutic restorations
03

In context

Dental Caries

1,138 studies on the registry are indexed under Dental Caries; 201 are open to participants now.

This study's enrollment of 3,345 is above the median of 60 across 936 interventional studies indexed under Dental Caries.

Browse Dental Caries studies →

Lead sponsor

NYU College of Dentistry is the lead sponsor of 10 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Any primary school with a previously employed caries prevention program operating in rural areas, with official Title 1 status, and located in a health professional shortage area. Within participating schools, all children are eligible to participate in the study. Those with informed consent and assent will receive care.

Exclusion criteria

Exclusion Criteria:

  • Children without informed consent or those with consent but without assent.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
3,345 participants (actual)

Study arms

  • Experimental
    Simple Prevention

    One drop (0.05 ml) of silver diamine fluoride (Advantage ArrestTM) solution at 38% concentration (2.24 F-ion mg/dose) will be dispensed per child. Posterior tooth surfaces to be treated will be dried, after which the SDF will be applied with a micro-brush to all asymptomatic carious lesions and to all pits and fissures on bicuspids and molar teeth for thirty seconds. Fluoride varnishes (5% NaF) will then be applied to all teeth. Dosage frequency will be twice-yearly.

    Device: Silver Diamine Fluoride · Device: Fluoride Varnishes

  • Active comparator
    Complex Prevention

    Pits and fissures on all bicuspids and molar teeth will be sealed with glass ionomer sealants (GC Fuji IX). Glass ionomer sealants (interim therapeutic restorations) will also be placed on all frank asymptomatic carious lesions. Fluoride varnishes (5% NaF) will then be applied to all teeth. Dosage frequency will be twice-yearly.

    Device: Fluoride Varnishes · Device: Glass Ionomer

Interventions

  • DeviceSilver Diamine Fluoride

    Silver diamine fluoride (SDF)

    Also known as: Advantage Arrest

  • DeviceFluoride Varnishes

    Fluoride varnish (FV)

  • DeviceGlass Ionomer

    Glass Ionomer Sealants (GC Fuji IX)

06

What researchers measure

Primary outcomes

  1. Number of Participants With Arrested Dental Caries, Assessed Using a Clinical Oral Examination

    For any participants with untreated dental caries on teeth at baseline treated with SDF/FV or Glass ionomer atraumatic restorative treatment (ART)/FV to arrest (control) the infection, what is the proportion of participants that stayed arrested

    Time frame: Two years

  2. Caries Prevention

    For teeth without carious lesions (sound teeth) treated with SDF/FV or Glass ionomer/FV, how many teeth developed caries over the course of observation

    Time frame: Five years

07

Results

Posted Feb 26, 2025

Participant flow

Participant flow — Overall Study
MilestoneSimple PreventionComplex Prevention
Started15581787
Completed13291529
Not completed229258
Withdrew: Lost to follow-up229258

Outcome measures

PrimaryNumber of Participants With Arrested Dental Caries, Assessed Using a Clinical Oral Examination

For any participants with untreated dental caries on teeth at baseline treated with SDF/FV or Glass ionomer atraumatic restorative treatment (ART)/FV to arrest (control) the infection, what is the proportion of participants that stayed arrested

Time frame:
Two years
Reported as:
Count of participants · Participants
Number of Participants With Arrested Dental Caries, Assessed Using a Clinical Oral Examination
ParticipantsSimple PreventionComplex Prevention
Number of Participants With Arrested Dental Caries, Assessed Using a Clinical Oral Examination4853
PrimaryCaries Prevention

For teeth without carious lesions (sound teeth) treated with SDF/FV or Glass ionomer/FV, how many teeth developed caries over the course of observation

Time frame:
Five years
Reported as:
Number · teeth
Caries Prevention
teethSimple PreventionComplex Prevention
Caries Prevention210179

Adverse events

Collected over Study participants were monitored for adverse events through study completion (5 years, 8 months; average per-participant duration 2.2 years).. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Simple Prevention0/1,558 (0%)0/1,558 (0%)0/1,558 (0%)
Complex Prevention0/1,787 (0%)0/1,787 (0%)0/1,787 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Simple PreventionComplex PreventionTotal
Mean7.0 ± 1.87.3 ± 1.87.2 ± 1.8
Sex: Female, Male
Sex: Female, Male(Participants)Simple PreventionComplex PreventionTotal
Female7848081592
Male7749791753
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)Simple PreventionComplex PreventionTotal
Hispanic/Latino132336
Black161430
White346522868
Asian101929
Multiple10919
Other1910
Unreported116211912353
Baseline untreated decay
Baseline untreated decay(Participants)Simple PreventionComplex PreventionTotal
Count of participants221276497
08

Study locations

1 site
  • New York University College of Dentistry
    New York, New York 10010, United States
09

References and documents

Publications

  • Ruff RR, Niederman R. School-based caries prevention using silver diamine fluoride: A pragmatic randomized trial in low-income rural children. medRxiv [Preprint]. 2024 Jun 25:2024.06.05.24308499. doi: 10.1101/2024.06.05.24308499. PubMed 38883737 ↗
  • Ruff RR, Niederman R. Comparative effectiveness of treatments to prevent dental caries given to rural children in school-based settings: protocol for a cluster randomised controlled trial. BMJ Open. 2018 Apr 13;8(4):e022646. doi: 10.1136/bmjopen-2018-022646. PubMed 29654053 ↗

Study documents

  • Protocol and statistical analysis plan · Feb 8, 2021

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Yes — Individual participant data could be shared with proper approval from participating organizations for relevant and appropriate requests.

Supporting information: Study protocol, Informed consent form

Time frame: Data will be available December 1, 2025 and for five years.

Access criteria: By request of the original principal investigators.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 26, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03448107
Lead sponsor
NYU College of Dentistry
Responsible party
Richard Niederman (Professor, NYU College of Dentistry) — Principal investigator
First posted
Feb 27, 2018
Start date
Sep 20, 2017
Primary completion
Jun 30, 2023
Completion
Jun 30, 2023
Results posted
Feb 26, 2025
Last update
Feb 26, 2025

Study contacts

Richard Niederman, DMD
principal investigator · NYU Langone Health
Ryan R Ruff, MPH, PhD
principal investigator · NYU Langone Health

Oversight

FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion